Cargando…
Amplification of HER2 is a marker for global genomic instability
BACKGROUND: Genomic alterations of the proto-oncogene c-erbB-2 (HER-2/neu) are associated with aggressive behavior and poor prognosis in patients with breast cancer. The variable clinical outcomes seen in patients with similar HER2 status, given similar treatments, suggests that the effects of ampli...
Autores principales: | Ellsworth, Rachel E, Ellsworth, Darrell L, Patney, Heather L, Deyarmin, Brenda, Love, Brad, Hooke, Jeffrey A, Shriver, Craig D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2571108/ https://www.ncbi.nlm.nih.gov/pubmed/18854030 http://dx.doi.org/10.1186/1471-2407-8-297 |
Ejemplares similares
-
Molecular Heterogeneity in Primary Breast Carcinomas and Axillary Lymph Node Metastases Assessed by Genomic Fingerprinting Analysis
por: Ellsworth, Rachel E, et al.
Publicado: (2015) -
Genomic Heterogeneity of Breast Tumor Pathogenesis
por: Ellsworth, Rachel E., et al.
Publicado: (2009) -
Differential Gene Expression in Primary Breast Tumors Associated with Lymph Node Metastasis
por: Ellsworth, Rachel E., et al.
Publicado: (2011) -
Breast Cancer in the Personal Genomics Era
por: Ellsworth, Rachel E., et al.
Publicado: (2010) -
Management of Incidental Findings in the Era of Next-generation Sequencing
por: Blackburn, Heather L., et al.
Publicado: (2015)